Accolade (ACCD) The 44th Annual William Blair Growth Stock Conference summary
Event summary combining transcript, slides, and related documents.
The 44th Annual William Blair Growth Stock Conference summary
31 Jan, 2026Strategic vision and market positioning
Focused on improving care and managing healthcare costs for employers, governments, and health plans, serving 12 million people across 1,200 customers nationwide.
Emphasizes a member-obsessed culture, following individuals through their care journey to prevent gaps in care.
Operates in a largely underpenetrated market of 30,000 potential commercial customers, providing significant growth opportunities.
Differentiates through a world-class technology stack and a unique data set, enabling scalable, personalized care.
Customer engagement rates reach 70%, driving downstream utilization of primary and preventative care solutions.
Technology and care delivery innovation
Integrates primary care physicians and behavioral health specialists into care teams, leveraging real-time data for coordinated care.
Uses advanced data integration, including claims and hospital admission data, to proactively engage members and reduce costs.
Offers rapid access to care, with 80% of visits occurring the same day, and shares data with existing primary care providers.
Employs AI and machine learning to automate administrative tasks, improve risk stratification, and enhance care recommendations.
Closed-loop reporting and real integration with partner solutions enable tracking of member engagement and program outcomes.
Financial performance and growth outlook
Fiscal 2025 guidance projects $480–$500 million in revenue and $15–$20 million in Adjusted EBITDA, with long-term targets of $1 billion revenue and $150–$200 million profit by fiscal 2029.
Consistent 20% CAGR over the past five years, with expanding gross margins currently at 49%.
Platform Connect revenues, a high-margin segment, have grown from $7 million in 2021 to an expected $50 million in 2024.
Customer retention exceeds 90%, with 30% of fees at risk tied to value delivery, and over 90% of that value realized annually.
Revenue diversification across direct employers and health plans supports resilience and continued growth.
Latest events from Accolade
- Revenue up 18% to $110.5M; FY25 guidance targets $460M–$475M and margin expansion.ACCD
Q1 20253 Feb 2026 - Profitable, diversified platform drives growth with integrated care, tech, and disciplined strategy.ACCD
Morgan Stanley 22nd Annual Global Healthcare Conference22 Jan 2026 - Q2 FY25 revenue up 10%, net loss narrows, and adjusted EBITDA loss narrows 68% year-over-year.ACCD
Q2 202519 Jan 2026 - Growing demand for advocacy and virtual care drives revenue and margin expansion.ACCD
Stephens 26th Annual Investment Conference | NASH202413 Jan 2026 - Integrated care, behavioral health, and data-driven engagement deliver strong outcomes and savings.ACCD
Piper Sandler 36th Annual Healthcare Conference11 Jan 2026